A randomized comparative study of the efficacy of Q-switched neodymium-doped yttrium aluminium garnet laser versus 4% hydroquinone in the treatment of melasma
Journal of Cutaneous and Aesthetic Surgery · 13.08.2026 · 1-9
DOI: 10.25259/jcas_56_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous and Aesthetic Surgery, online erschienen am 13.08.2026. Verfasst von Aneesha Puri und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Objectives
The objective of the study is to compare the therapeutic efficacy and side effects of Q-switched neodymium-doped yttrium aluminium garnet (Nd:YAG) laser versus topical 4% hydroquinone cream in the treatment of melasma. Material and Methods: Eighty patients with clinically diagnosed melasma were randomly assigned to two groups: Group A received three sessions of Q-switched Nd:YAG laser 4 weeks apart, while Group B applied 4% hydroquinone cream once daily for 12 weeks. Efficacy was assessed using modified melasma area and severity index (mMASI) scores; investigator’s global assessment (IGA); and patient global assessment (PGA) at weeks 4, 8, and 12.
Results
In our study, the mean age was 34.48 ± 6.7 years, with a male-to-female ratio of 1:4. Both groups showed statistically significant reductions in mMASI scores over 12 weeks, with Group B consistently demonstrating lower mMASI scores (Week 12: Group A 3.97 ± 2.59 vs. Group B 2.98 ± 1.93; p = 0.023). Patient and IGA scores also improved in both groups, with Group B showing significantly better patient-reported outcomes at week 12 ( p = 0.043). The mean percentage reduction in mMASI increased progressively over time in both treatment arms. Although Group B showed numerically greater percentage reduction at all visits, the inter-group differences were not statistically significant at any time point. Side effects were mild and comparable; erythema was more common in Group B (17.50% vs. 5%).
Conclusion
Both treatments produced significant improvement in melasma over 12 weeks. Although hydroquinone achieved lower absolute mMASI scores and greater patient-reported improvement at week 12, the percentage reduction in mMASI between the groups was comparable, suggesting that both modalities are effective treatment options.
Zitieren
APA
Puri, A., Vardhan, K. H., Goel, S., & Tyagi, H. (2026). A randomized comparative study of the efficacy of Q-switched neodymium-doped yttrium aluminium garnet laser versus 4% hydroquinone in the treatment of melasma. Journal of Cutaneous and Aesthetic Surgery, 0, 1-9. https://doi.org/10.25259/jcas_56_2026
Vancouver
Puri A, Vardhan KH, Goel S, Tyagi H. A randomized comparative study of the efficacy of Q-switched neodymium-doped yttrium aluminium garnet laser versus 4% hydroquinone in the treatment of melasma. Journal of Cutaneous and Aesthetic Surgery. 2026;0:1-9. doi:10.25259/jcas_56_2026
BibTeX
@article{Puri2026,
author = {Puri, Aneesha and Vardhan, K. Harsha and Goel, Shitij and Tyagi, Harsh},
title = {A randomized comparative study of the efficacy of Q-switched neodymium-doped yttrium aluminium garnet laser versus 4% hydroquinone in the treatment of melasma},
journal = {Journal of Cutaneous and Aesthetic Surgery},
year = {2026},
volume = {0},
pages = {1--9},
doi = {10.25259/jcas_56_2026}
}
EUVIMED